Jeffrey Glenn Net Worth & Insider Trades

Jeffrey Glenn Eiger Biopharmaceuticals, Inc

As of March 11, 2022

What is Jeffrey Glenn's Net Worth?

The current estimated net worth of Eiger Biopharmaceuticals, Inc's Jeffrey Glenn is estimated to be about $225.04K . Jeffrey Glenn owns about 156,064 units of Eiger Biopharmaceuticals, Inc common stock. In the last 6 years at Eiger Biopharmaceuticals, Inc, Jeffrey Glenn has sold an estimated value of $0 worth.

What is Jeffrey Glenn's Past Insider Trading?

Jeffrey Glenn's largest purchase order was 15,460 units , worth over $196.88K on November 21, 2016. In total, Jeffrey Glenn has made about 11 transactions over 6 years of their time at Eiger Biopharmaceuticals, Inc. Jeffrey Glenn usually trades in March, with the busiest year in 2020. The most recent transaction was a purchase order of 10,000 units , worth over $114.57K on August 12, 2020.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Jeffrey Glenn's' Mailing Address?

  • Mailing address is 350 Cambridge Avenue, Suite 350 Palo Alto CA 94306 CA

Eiger Biopharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
David A. Cory 2020 $590,584 - - $829,564 $393,360 $16,671 $1,830,179
David A. Cory 2019 $565,833 - - $2,009,820 $285,000 $11,200 $2,871,853
Sriram Ryali 2020 $381,550 - - $234,442 $173,272 $12,296 $801,559
Sriram Ryali 2019 $335,000 - - $662,211 $117,250 $9,732 $1,124,193
Eldon Mayer 2020 $385,569 $100,000 $92,700 $1,199,520 $169,256 $2,328 $1,949,373
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1305253/000119312521137193/d146195ddef14a.htm

What are Eiger Biopharmaceuticals, Inc's Past Insider Trades?

Eiger Biopharmaceuticals, Inc's most recent insider trade came on August 18, 2022 by David Apelian who sold 5,000 units worth $49.03K . In the last 6 years, insiders at Eiger Biopharmaceuticals, Inc have sold an estimated value of $3.02M and bought an estimated value of $4.61M worth of shares. Insider trading is most common in March, with the busiest year in 2019. The most active traders at the company are John Thomas Dietz,  Eldon Mayer III, Ex VP & Chief Commerc. Officer,  and David Cory, President and CEO .

Eiger BioPharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1